These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 18506358

  • 1. Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.
    Drel VR, Pacher P, Ali TK, Shin J, Julius U, El-Remessy AB, Obrosova IG.
    Int J Mol Med; 2008 Jun; 21(6):667-76. PubMed ID: 18506358
    [Abstract] [Full Text] [Related]

  • 2. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
    Drel VR, Xu W, Zhang J, Kador PF, Ali TK, Shin J, Julius U, Slusher B, El-Remessy AB, Obrosova IG.
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
    [Abstract] [Full Text] [Related]

  • 3. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
    Obrosova IG, Pacher P, Szabó C, Zsengeller Z, Hirooka H, Stevens MJ, Yorek MA.
    Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
    [Abstract] [Full Text] [Related]

  • 4. Na+/H+-exchanger-1 inhibition counteracts diabetic cataract formation and retinal oxidative-nitrative stress and apoptosis.
    Lupachyk S, Stavniichuk R, Komissarenko JI, Drel VR, Obrosov AA, El-Remessy AB, Pacher P, Obrosova IG.
    Int J Mol Med; 2012 Jun; 29(6):989-98. PubMed ID: 22407349
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.
    Obrosova IG, Maksimchyk Y, Pacher P, Agardh E, Smith ML, El-Remessy AB, Agardh CD.
    Int J Mol Med; 2010 Jul; 26(1):135-42. PubMed ID: 20514433
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Aldose reductase / polyol inhibitors for diabetic retinopathy.
    Obrosova IG, Kador PF.
    Curr Pharm Biotechnol; 2011 Mar 01; 12(3):373-85. PubMed ID: 20939801
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathy.
    Stavniichuk R, Shevalye H, Hirooka H, Nadler JL, Obrosova IG.
    Biochem Pharmacol; 2012 Apr 01; 83(7):932-40. PubMed ID: 22285226
    [Abstract] [Full Text] [Related]

  • 14. Biochemical Evidence Indicates the Preventive Effect of Resveratrol and Nicotinamide in the Treatment of STZ-induced Diabetic Cataract.
    Singh A, Bodakhe SH.
    Curr Eye Res; 2021 Jan 01; 46(1):52-63. PubMed ID: 32631099
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
    Zhang H, Gao Y, Zhang J, Wang K, Jin T, Wang H, Ruan K, Wu F, Xu Z.
    J Ethnopharmacol; 2020 Jun 12; 255():112773. PubMed ID: 32199990
    [Abstract] [Full Text] [Related]

  • 18. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
    Sun W, Oates PJ, Coutcher JB, Gerhardinger C, Lorenzi M.
    Diabetes; 2006 Oct 12; 55(10):2757-62. PubMed ID: 17003340
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.
    Ilnytska O, Lyzogubov VV, Stevens MJ, Drel VR, Mashtalir N, Pacher P, Yorek MA, Obrosova IG.
    Diabetes; 2006 Jun 12; 55(6):1686-94. PubMed ID: 16731831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.